IL6 and thrombocytosis disease: Increasing numbers of studies suggested that the proinflammatory cytokines released by tumors, like interleukin-1 (IL-1), interleukin-3 (IL-3), and interleukin-6 (IL-6), can promote megakaryocyte proliferation, and lead to thrombocytosis gradually [10].